Tenaya Therapeutics (TNYA) Profit After Tax (2020 - 2026)

Tenaya Therapeutics' Profit After Tax history runs 7 years deep, the most recent figure standing at -$19.3 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 28.26% year-over-year to -$19.3 million; the TTM figure through Mar 2026 stood at -$83.1 million (up 21.36% YoY), while the FY2025 annual figure was -$90.6 million, up 18.45% from the prior year.
• Profit After Tax for Q1 2026 stood at -$19.3 million, up from -$20.2 million in the prior quarter.
• The five-year high for Profit After Tax was -$19.3 million in Q1 2026, with the low at -$33.3 million in Q2 2023.
• The 5-year median for Profit After Tax is -$29.1 million (2023), against an average of -$27.5 million.
• The sharpest annual moves came in 2022 and 2026: Profit After Tax slumped 137.1% in 2022, then rose 28.26% in 2026.
• Tenaya Therapeutics' Profit After Tax stood at -$33.1 million in 2022, then climbed by 10.46% to -$29.7 million in 2023, then increased by 19.67% to -$23.8 million in 2024, then rose by 15.12% to -$20.2 million in 2025, then increased by 4.71% to -$19.3 million in 2026.
• Business Quant data shows TNYA's Profit After Tax at -$19.3 million in Q1 2026, -$20.2 million in Q4 2025, and -$20.3 million in Q3 2025.